SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma

Assadipour, Yasmine; Sadowski Veuthey, Mercedes Samira Doris; Alimchandani, Meghna; Quezado, Martha; Steinberg, Seth M; Nilubol, Naris; Patel, Dhaval; Prodanov, Tamara; Pacak, Karel; Kebebew, Electron

doi:10.1016/j.surg.2016.05.050

Scientific article

English

SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma

ContributorsAssadipour, Yasmine; Sadowski Veuthey, Mercedes Samira Doris; Alimchandani, Meghna; Quezado, Martha; Steinberg, Seth M; Nilubol, Naris; Patel, Dhaval; Prodanov, Tamara; Pacak, Karel; Kebebew, Electron

Published inSurgery, vol. 161, no. 1, p. 230-239

Publication date2017

Abstract

A staging/prognostic system has long been desired to better categorize pheochromocytoma/paraganglioma which can be very aggressive in the setting of SDHB mutations.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Cancer du poumon et mésothéliome pleural malin (944)

Citation (ISO format)

ASSADIPOUR, Yasmine et al. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. In: Surgery, 2017, vol. 161, n° 1, p. 230–239. doi: 10.1016/j.surg.2016.05.050

Article (Published version)

Identifiers

PID : unige:93701
DOI : 10.1016/j.surg.2016.05.050
PMID : 27839933

Journal ISSN0039-6060

418views

0downloads

Creation03/02/2017 1:43:00 PM

First validation03/02/2017 1:43:00 PM

Update time03/15/2023 1:36:28 AM

Status update03/15/2023 1:36:27 AM

Last indexation10/31/2024 6:47:26 AM

Archive ouverte UNIGE

SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma

A staging/prognostic system has long been desired to better categorize pheochromocytoma/paraganglioma which can be very aggressive in the setting of SDHB mutations.

Technical informations